BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun YL, Cai JQ, Liu F, Bi XY, Zhou LP, Zhao XH. Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer. World J Gastroenterol 2015; 21(38): 10840-10852 [PMID: 26478675 DOI: 10.3748/wjg.v21.i38.10840]
URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10840.htm
Number Citing Articles
1
Yameng Zhang, Yufei Gao, Youhe Gao. Early changes in the urine proteome in a rat liver tumour modelPeerJ 2020; 8: e8462 doi: 10.7717/peerj.8462
2
Fernanda Villarruel-Melquiades, María Eugenia Mendoza-Garrido, Claudia M García-Cuellar, Yesennia Sánchez-Pérez, Julio Isael Pérez-Carreón, Javier Camacho. Current and novel approaches in the pharmacological treatment of hepatocellular carcinomaWorld Journal of Gastroenterology 2023; 29(17): 2571-2599 doi: 10.3748/wjg.v29.i17.2571
3
Huan-Xi Li, Xiang-Yu Sun, Shi-Ming Yang, Qing Wang, Zhen-Yu Wang. Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancerPathology - Research and Practice 2018; 214(5): 655 doi: 10.1016/j.prp.2018.03.026
4
Sangeeta Jaiswal, Bishnu Joshi, Jing Chen, Fa Wang, Michael K. Dame, Jason R. Spence, Gina M. Newsome, Erica L. Katz, Yatrik M. Shah, Sadeesh K. Ramakrishnan, Gaoming Li, Miki Lee, Henry D. Appelman, Rork Kuick, Thomas D. Wang. Membrane Bound Peroxiredoxin-1 Serves as a Biomarker for In Vivo Detection of Sessile Serrated AdenomasAntioxidants & Redox Signaling 2022; 36(1-3): 39 doi: 10.1089/ars.2020.8244
5
Narumi OTSUKA, Kairi ISHIMARU, Mami MURAKAMI, Minami GOTO, Akihiro HIRATA, Hiroki SAKAI. The immunohistochemical detection of peroxiredoxin 1 and 2 in canine spontaneous vascular endothelial tumorsJournal of Veterinary Medical Science 2022; 84(7): 914 doi: 10.1292/jvms.22-0102
6
Hui Ma, Christine Loscher, Anne Parle-McDermott, Jenny Fitzgerald, Julie Meneely, Christopher Elliott, Richard Welten, Geofrey J. Mchau, Edna Makule, Revocatus Machunda, Yun Yun Gong, Martin Kimanya, Aoife Crawley, Ivan Maguire, Caroline Murphy, Richard O’Kennedy. Evaluation of a point-of-use device used for autoantibody analysis and its potential for following microcystin leucine-arginine exposureFrontiers in Sensors 2024; 5 doi: 10.3389/fsens.2024.1302520
7
Meilin Ye, Ting Liu, Shanshan Liu, Rong Tang, Hongrui Liu, Fan Zhang, Shenglei Luo, Minqi Li. Peroxiredoxin 1 regulates crosstalk between pyroptosis and autophagy in oral squamous cell carcinoma leading to a potential pro-survivalCell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01720-7
8
Kun You, Peisheng Sun, Zhongyi Yue, Jian Li, Wancheng Xiong, Jianguo Wang. NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathwayExperimental Cell Research 2017; 352(2): 375 doi: 10.1016/j.yexcr.2017.02.032
9
Jie Zhao, Jinhui Guo, Yanan Wang, Qiancheng Ma, Yu Shi, Feng Cheng, Qiliang Lu, Wen Fu, Guangxiong Ouyang, Ji Zhang, Qiuran Xu, Xiaoge Hu. Research Progress of DUB Enzyme in Hepatocellular CarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.920287
10
Chenbo Ding, Xiaobo Fan, Guoqiu Wu. Peroxiredoxin 1 – an antioxidant enzyme in cancerJournal of Cellular and Molecular Medicine 2017; 21(1): 193 doi: 10.1111/jcmm.12955
11
Arianna Nicolussi, Sonia D'Inzeo, Carlo Capalbo, Giuseppe Giannini, Anna Coppa. The role of peroxiredoxins in cancerMolecular and Clinical Oncology 2017; 6(2): 139 doi: 10.3892/mco.2017.1129
12
Qiongzhen Chen, Jinmeng Li, Xiaoning Yang, Junfeng Ma, Fanghua Gong, Yu Liu. Prdx1 promotes the loss of primary cilia in esophageal squamous cell carcinomaBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06898-y
13
Gary A. Clawson, Gail L. Matters, Ping Xin, Christopher McGovern, Eric Wafula, Claude dePamphilis, Morgan Meckley, Joyce Wong, Luke Stewart, Christopher D’Jamoos, Naomi Altman, Yuka Imamura Kawasawa, Zhen Du, Loren Honaas, Thomas Abraham, Surinder K. Batra. "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinomaPLOS ONE 2017; 12(9): e0184451 doi: 10.1371/journal.pone.0184451
14
Yu Zhang, Xia‐Xin Wu, Shuang Li, Jin‐Feng Wu, Sen Han, Zhi‐Jie Lin, Shi‐Zhen Ding, Wei‐Juan Gong. Peroxiredoxin 1 as an inflammatory marker in diarrhea‐predominant and postinfectious irritable bowel syndromeNeurogastroenterology & Motility 2020; 32(2) doi: 10.1111/nmo.13741
15
Yiqi Zhang, Kejia Wu, Yuxin Liu, Shuangling Sun, Yue Shao, Qingxiu Li, Xinying Sui, Changzhu Duan. UHRF2 promotes the malignancy of hepatocellular carcinoma by PARP1 mediated autophagyCellular Signalling 2023; 109: 110782 doi: 10.1016/j.cellsig.2023.110782
16
Lianxiang Luo, Xinyue Yao, Jing Xiang, Fangfang Huang, Hui Luo. Identification of ferroptosis-related genes for overall survival prediction in hepatocellular carcinomaScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14554-7
17
Jan F. Stevens, Johana S. Revel, Claudia S. Maier. Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer ModelsAntioxidants & Redox Signaling 2018; 29(16): 1589 doi: 10.1089/ars.2017.7404
18
Zuzana Cockova, Hana Ujcikova, Petr Telensky, Jiri Novotny. Protein profiling of SH-SY5Y neuroblastoma cells: The effect of rheinJournal of Biosciences 2019; 44(4) doi: 10.1007/s12038-019-9908-0
19
Junjun Zhang, Xi Zhang, Jie Li, Zewen Song. Systematic analysis of the ABC transporter family in hepatocellular carcinoma reveals the importance of ABCB6 in regulating ferroptosisLife Sciences 2020; 257: 118131 doi: 10.1016/j.lfs.2020.118131
20
Bing Han, Hye-Jun Shin, In Seon Bak, Yesol Bak, Ye-Lin Jeong, Taeho Kwon, Young-Ho Park, Hu-Nan Sun, Cheol-Hee Kim, Dae-Yeul Yu. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesisOncotarget 2016; 7(42): 68044 doi: 10.18632/oncotarget.11172
21
Yao An, Jingwen Jiang, Li Zhou, Jinyu Shi, Ping Jin, Lei Li, Liyuan Peng, Siyu He, Wenhui Zhang, Canhua Huang, Bingwen Zou, Na Xie. Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinomaCancer Letters 2021; 521: 210 doi: 10.1016/j.canlet.2021.08.023